histanaz

Generic: pseudoephedrine hcl, pyrilamine maleate

Labeler: capital pharmaceutical, llc
NDC Directory HUMAN OTC DRUG OTC MONOGRAPH DRUG Inactive Finished

Drug Facts

Product Profile

Brand Name histanaz
Generic Name pseudoephedrine hcl, pyrilamine maleate
Labeler capital pharmaceutical, llc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

pseudoephedrine hydrochloride 60 mg/1, pyrilamine maleate 30 mg/1

Manufacturer
Capital Pharmaceutical, LLC

Identifiers & Regulatory

Product NDC 29978-129
Product ID 29978-129_3e87d0f3-f16d-5972-e063-6294a90acc8a
Product Type HUMAN OTC DRUG
Marketing Category OTC MONOGRAPH DRUG
Application Number M012
Listing Expiration 2026-12-31
Marketing Start 2025-09-08

Pharmacologic Class

Classes
adrenergic alpha-agonists [moa] alpha-adrenergic agonist [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 29978129
Hyphenated Format 29978-129

Supplemental Identifiers

RxCUI
2727351
UNII
6V9V2RYJ8N R35D29L3ZA

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name histanaz (source: ndc)
Generic Name pseudoephedrine hcl, pyrilamine maleate (source: ndc)
Application Number M012 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 60 mg/1
  • 30 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE (29978-129-10)
source: ndc

Packages (1)

Ingredients (2)

pseudoephedrine hydrochloride (60 mg/1) pyrilamine maleate (30 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "3e87d0f3-f16d-5972-e063-6294a90acc8a", "openfda": {"unii": ["6V9V2RYJ8N", "R35D29L3ZA"], "rxcui": ["2727351"], "spl_set_id": ["3e87d0f3-f16c-5972-e063-6294a90acc8a"], "manufacturer_name": ["Capital Pharmaceutical, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (29978-129-10)", "package_ndc": "29978-129-10", "marketing_start_date": "20250908"}], "brand_name": "Histanaz", "product_id": "29978-129_3e87d0f3-f16d-5972-e063-6294a90acc8a", "dosage_form": "TABLET", "pharm_class": ["Adrenergic alpha-Agonists [MoA]", "alpha-Adrenergic Agonist [EPC]"], "product_ndc": "29978-129", "generic_name": "Pseudoephedrine HCL, Pyrilamine Maleate", "labeler_name": "Capital Pharmaceutical, LLC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Histanaz", "active_ingredients": [{"name": "PSEUDOEPHEDRINE HYDROCHLORIDE", "strength": "60 mg/1"}, {"name": "PYRILAMINE MALEATE", "strength": "30 mg/1"}], "application_number": "M012", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20250908", "listing_expiration_date": "20261231"}